The rational use of mechanical support and drugs in cardiogenic shock based on the cardioprotection paradigm

J Cardiovasc Med (Hagerstown). 2024 Jul 1;25(7):488-490. doi: 10.2459/JCM.0000000000001627. Epub 2024 May 31.

Authors

Federico Pappalardo^{1

2}, Andrea Montisci³, Letizia F Bertoldi⁴, Serena Ambrosi³, Patrick Hunziker⁵

Affiliations

¹ Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, AO SS Antonio and Biagio and Cesare Arrigo, Alessandria, Milan.
² Cardiac Anesthesia and Intensive Care, AOU Maggiore della Carità, Novara.
³ Division of Cardiothoracic Intensive Care, ASST Spedali Civili, Brescia.
⁴ Cardio Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
⁵ Intensive Care Unit, University Hospital Basel, Switzerland.

PMID: 38829937
DOI: 10.2459/JCM.0000000000001627

No abstract available

MeSH terms

Cardiotonic Agents* / therapeutic use
Heart-Assist Devices*
Humans
Shock, Cardiogenic* / etiology
Shock, Cardiogenic* / physiopathology
Shock, Cardiogenic* / therapy
Treatment Outcome

Substances

Cardiotonic Agents